Thompson Davis & Co’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-125
Closed -$2K 1139
2016
Q3
$2K Buy
+125
New +$2K ﹤0.01% 994
2016
Q2
Sell
-250
Closed -$4K 1096
2016
Q1
$4K Buy
+250
New +$4K 0.01% 830